The Waltham-based genetic test maker said the deal, which closed June 30, is part of its move to focus on its core genetic testing business. Interleukin bought Boca Raton, Fla.-based AJG Brands Inc. for $7.5 million in August 2006.
It could also be a part of the company’s quest to regain the good graces of the New York Stock Exchange. Interleukin ran afoul of the exchange two days before Christmas 2008, when its stockholders equity dropped below the $6 million threshold required by the NYSE and it posted five consecutive quarters of net and operating losses.
In March, Interleukin slid further toward a de-listing after the NYSE rejected its plan to regain compliance with the exchange’s rules. The company appealed the decision and is awaiting a hearing.